The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 11, 2009

Filed:

Jan. 26, 2005
Applicants:

Yong-chul Kim, Gwangju, KR;

SI Wouk Kim, Gwangju, KR;

Tae Sung Kim, Gwangju, KR;

Sang Kook Lee, Seoul, KR;

Jae IL Kim, Gwangju, KR;

Jung-hoon Yoon, Gwangju, KR;

Sang-gun Ahn, Gwangju, KR;

Myoung Ju Moon, Daegu, KR;

Inventors:

Yong-Chul Kim, Gwangju, KR;

Si Wouk Kim, Gwangju, KR;

Tae Sung Kim, Gwangju, KR;

Sang Kook Lee, Seoul, KR;

Jae Il Kim, Gwangju, KR;

Jung-Hoon Yoon, Gwangju, KR;

Sang-Gun Ahn, Gwangju, KR;

Myoung Ju Moon, Daegu, KR;

Assignee:

Anygen Co., Ltd., Gwangju, KR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 209/34 (2006.01); A61K 31/4015 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to an indirubin derivative having anticancer property by inhibiting cell proliferation as to human cancer cell line. More particularly, this invention provides the synthesis of indirubin derivative known as CDK(Cyclin-dependent kinase) inhibitor. Further, inhibition activity of proliferation as to human cancer cell line and apoptosis against induced-differentiation of said indirubin derivative are researched to develop a novel indirubin derivative having efficacious anticancer properties as to various human cell lines.


Find Patent Forward Citations

Loading…